← Leaderboards
Matthew Michael Ippolito
Johns Hopkins University
$3,648,189
Attributed
$4,086,606
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,086,606 · 7
By mechanism
R21$876,834 · 2
T32$847,091 · 1
K23$772,640 · 1
U19$708,223 · 1
R01$636,193 · 1
R34$245,625 · 1
Top collaborators
- Benjamin D Haeffele2 shared
- Mark A Travassos2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William Kuang-Yao Pan$4,538,330
- Theresa A Shapiro$12,921,052
- William J Moss$14,737,348
- David Joseph Sullivan$9,405,920
- Peter G Vekilov$2,776,224
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionMalariaParasitesAfrica South Of The SaharaSiteChildPlasmodium FalciparumZambiaCessation Of LifeDrug ResistanceAreaVariantPublic HealthEpidemiologyResearch PersonnelPharmaceutical PreparationsGenomicsCostLaboratoriesClinical PharmacologySpecimenResearch InstituteGenotypeArtemisinins
Grant awards (14)
Integrative Multiomics to Probe Interactions of the Gut Microbiome with Malaria Pathogenesis and Antimalarial Pharmacokinetics in Humans$636,193
R01 · FY2025 · AI · contact PI
Clinical Pharmacology Training Program$424,916
T32 · FY2025 · GM · contact PI
Development and Application of Innovative Malaria Surveillance Data Streams and Tools in Three Transmission Settings in Zambia$362,111
U19 · FY2025 · AI · contact PI
Parasite variant surface antigen expression and immune gaps in severe malaria$196,337
R21 · FY2025 · AI
Clinical Pharmacology Training Program$422,175
T32 · FY2024 · GM · contact PI
Development and Application of Innovative Malaria Surveillance Data Streams and Tools in Three Transmission Settings in Zambia$346,112
U19 · FY2024 · AI · contact PI
Parasite variant surface antigen expression and immune gaps in severe malaria$252,213
R21 · FY2024 · AI
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications$196,745
R21 · FY2024 · AI · contact PI
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications$231,539
R21 · FY2023 · AI · contact PI
Clinical Pharmacology of Malaria Control and Elimination: Pharmacodynamics ofArtemisinin-based Combination Agents and their Barriers to Drug Resistance$190,080
K23 · FY2023 · AI · contact PI
The Averting Readmissions for Malaria and Outpatient Reinfections (ARMOR) Trial$245,625
R34 · FY2022 · AI · contact PI
Clinical Pharmacology of Malaria Control and Elimination: Pharmacodynamics ofArtemisinin-based Combination Agents and their Barriers to Drug Resistance$190,080
K23 · FY2022 · AI · contact PI
Clinical Pharmacology of Malaria Control and Elimination: Pharmacodynamics ofArtemisinin-based Combination Agents and their Barriers to Drug Resistance$194,080
K23 · FY2021 · AI · contact PI
Clinical Pharmacology of Malaria Control and Elimination: Pharmacodynamics ofArtemisinin-based Combination Agents and their Barriers to Drug Resistance$198,400
K23 · FY2020 · AI · contact PI